Homeopathy
DOI: 10.1055/s-0040-1709668
Original Research Article
The Faculty of Homeopathy

In Vitro Assessment of Homeopathic Potencies of Hydrastis canadensis on Hormone-Dependent and Independent Breast Cancer

Sabiha Khan
1  Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Uttar Pradesh, India
,
Debadatta Nayak
2  Central Council for Research in Homeopathy, New Delhi, India
,
Anil Khurana
2  Central Council for Research in Homeopathy, New Delhi, India
,
Raj Kumar Manchanda
2  Central Council for Research in Homeopathy, New Delhi, India
,
Chanderdeep Tandon
3  Amity Institute of Biotechnology, Amity University, Uttar Pradesh, India
,
1  Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Uttar Pradesh, India
› Author Affiliations
Funding This work was financially supported by the Central Council for Research in Homoeopathy (CCRH), Project No. 17–210/2013–14/CCRH/Tech/Coll/Biotech, Ministry of AYUSH, Govt. of India and performed at Amity University, Noida, India.
Further Information

Publication History

18 September 2019

13 February 2020

Publication Date:
01 July 2020 (online)

Abstract

Background Breast cancer is the second leading cause of cancer-related deaths in women. Conventional treatment such as chemotherapy, hormonal therapy and radiotherapy has decreased the mortality rate among cancer patients but has also revealed long-term side effects. Drug resistance and toxicity to normal cells compound the problems associated with the use of modern medicines. Hence, complementary or alternative treatment options are being explored. The current study, using different homeopathic potencies of Hydrastis canadensis, was conducted to distinguish between any effects they might have on hormone-dependent and independent breast cancer.

Materials and Methods The cytotoxic effect of homeopathic medicine Hydrastis on hormone-dependent (MCF 7) and hormone-independent (MDA-MB-468) breast cancer cells was assessed using viability and colony-forming assays after 48 or 72 hours of treatment. Flow cytometry-based Annexin V-PI (propidium iodide), caspase 3 and cell cycle analysis was performed following treatment of cells with mother tincture or various potencies of Hydrastis (1C, 2C, 30C, 200C).

Results Different potencies of Hydrastis displayed selective cytotoxic effects against MCF 7 cells, but only marginal effects against MDA-MB-468. The maximum cytotoxicity was established in the case of 1C following 72 hours of treatment. Treatment of breast cancer cells revealed an increase in the G0/G1 cell population, along with an increase in the caspase 3 levels and induction of apoptosis.

ConclusionHydrastis may have a selective cytotoxic effect against hormone-dependent breast cancer MCF 7 cells, leading to cell cycle arrest in the G0/G1 phase, which could be the plausible reason for the induction of apoptosis. The results need to be validated in vivo.

Highlights

Hydrastis is selectively cytotoxic against hormone-dependent breast cancer cells.


• The effect is time dependent and is in order MT >1C.


• The effect is irreversible in the case of MT.


• The mode of cell death can be attributed to caspase 3-dependent apoptosis.


Note

The study was performed as part of the PhD thesis of the first author.


Supplementary Material